Fast-acting insulin analogs
Van Doorn, L.G.
Nederlands Tijdschrift Voor Geneeskunde 142(20): 1165-1166
1998
ISSN/ISBN: 0028-2162 PMID: 9623241 Document Number: 490286
Document emailed within 1 workday
Related Documents
2005: Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight MMWFortschrittederMedizin 147(33-34): 45Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Nakazawa, T.; Chance, R.E. 1997: Basis for Insulin Lispro: physicochemical approach to fast-acting insulin analog Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 293-297
Wolffenbuttel, B.H.; Heine, R.J. 1998: Short-acting insulin analogs Nederlands Tijdschrift Voor Geneeskunde 142(8): 397-400
Holleman, F.; Hoekstra, J.B.L. 2004: Long-acting insulin analogs: progressing slowly Nederlands Tijdschrift Voor Geneeskunde 148(34): 1668-1669
Yokono, K. 2002: Rapid-acting insulin analogs--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 480-484
Huvers, F. 2004: Long acting insulin analogs: possibly more stable glucose regulation Nederlands Tijdschrift Voor Geneeskunde 148(34): 1674-1678
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41
Yokono, K. 2001: Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2127-2133
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Morishita, H. 2015: Premixed insulin and intermediate-acting insulin Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 453-457
Shimoda, S.; Nishida, K.; Sakakida, M.; Konno, Y.; Ichinose, K.; Uehara, M.; Nowak, T.; Shichiri, M. 1997: Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas Frontiers of Medical and Biological Engineering: the International Journal of the Japan Society of Medical Electronics and Biological Engineering 8(3): 197-211
Bucher, B.; Koch, B.; Mialhe, C. 1973: On the existence of a fast-acting negative feedback control of ACTH-corticosterone secretion Journal de Physiologie 66(2): 199-209
Kuzuya, T. 1976: Structure and activity of insulin and its analogs Nihon Rinsho. Japanese Journal of Clinical Medicine 34(3): 632-638
Koivisto, V. 1999: Insulin analogs and new oral antidiabetic drugs Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202
Stiefelhagen, P. 2011: When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs? MMW Fortschritte der Medizin 153(1-2): 14
Kobayashi, T. 2001: Efficacy, safety and indication of newly developed insulin analogs Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2165-2172
Yang, D-jie.; Zhang, S.; He, W-ling.; Chen, H-yun.; Cai, S-rong.; Chen, C-qi.; Song, X-ming.; Cui, J.; Ma, J-Ping.; Zhang, C-Hua.; He, Y-Long. 2012: Fast track surgery accelerates the recovery of postoperative insulin sensitivity Chinese Medical Journal 125(18): 3261-3265